drugset / Trial / NCT01362491

Ibuprofen Sodium Tension Headache Study

NCT01362491

Phase 3 Completed 226 enrolled Pfizer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will compare the ability of a single-dose of a novel ibuprofen formulation to relieve pain compared to placebo and standard ibuprofen in the treatment of tension-type headache

Timeline

Start
2011-06
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 400 mg Oral

Indications

No indication recorded.